CTOs on the Move

H.I.M. ON CALL

www.himoncall.com

 
H.I.M. ON CALL is a Allentown, PA-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.himoncall.com
  • 1033 Hamilton St Ste 2
    Allentown, PA USA 18101
  • Phone: 610.435.5724

Executives

Name Title Contact Details

Similar Companies

McKissock

McKissock provides online education to licensed professionals in real estate, health care and personal care sectors via multiple web properties and brands. We believe that everyone is entitled to professional opportunities. We strive to offer a personal, enriching experience, provide relevant, accessible information, and empower people to boldly advance their careers.

LEVEL Studios

LEVEL Studios is a San Luis Obispo, CA-based company in the Business Services sector.

Legacy Imports Inc

Legacy Imports Inc is a West Palm Beach, FL-based company in the Business Services sector.

Vilms

Vilms Incorporated is a Springfield, VA-based company in the Business Services sector.

InnoCare Pharma 诺诚健华(HKEX: 09969; SSE: 688428)

InnoCare Pharma is a commercial stage biopharmaceutical company dedicated to discovering, developing, and commercializing best-in-class and/or first-in-class drugs for the treatment of cancer and autoimmune diseases. InnoCare has strong in-house innovation capabilities, holding multiple foreign and domestic patents with a rich product pipeline target liquid tumors, solid tumors, and autoimmune diseases. Our team has discovered and developed a strong pipeline. InnoCare was co-founded by Professor Shi Yigong, a world-renowned structural biologist, and Dr. Cui Jisong, an outstanding leader in the biopharmaceutical industry. We have over 1000 employees. Our core R&D staff brings rich experience from the worlds top pharmaceutical companies, such as Pfizer, GSK, Bristol-Myers Squibb, Merck, Johnson & Johnson, Bayer, etc. We are a truly global biopharmaceutical company with sites in Beijing, Nanjing, Shanghai, and Guangzhou, Hong Kong and Unites States. On March 23, 2020, InnoCare officially listed on the Hong Kong Stock Exchange (code: 9969). And on Sept. 21, 2023, InnoCare successfully got listed on STAR Board of Shanghai Stock Exchange (code: 688428). Our vision is to become a world-class biopharma leader to address the unmet medical needs globally.